These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9154473)

  • 21. Pseudo-outbreaks of Stenotrophomonas maltophilia on an intensive care unit in England.
    Waite TD; Georgiou A; Abrishami M; Beck CR
    J Hosp Infect; 2016 Apr; 92(4):392-6. PubMed ID: 26876747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients.
    Villarino ME; Stevens LE; Schable B; Mayers G; Miller JM; Burke JP; Jarvis WR
    Infect Control Hosp Epidemiol; 1992 Apr; 13(4):201-6. PubMed ID: 1593100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia.
    Spencer RC
    J Hosp Infect; 1995 Jun; 30 Suppl():453-64. PubMed ID: 7560984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and clinical characteristics of Stenotrophomonas maltophilia infections in neonates.
    Mutlu M; Yılmaz G; Aslan Y; Bayramoğlu G
    J Microbiol Immunol Infect; 2011 Dec; 44(6):467-72. PubMed ID: 21606009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk factors and etiological analysis of ventilator-associated pneumonia: three year's cases analysis of intensive care unit in county hospital].
    Hu Z; Zhou S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Oct; 30(10):933-938. PubMed ID: 30439311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen.
    Sanyal SC; Mokaddas EM
    J Chemother; 1999 Feb; 11(1):28-33. PubMed ID: 10078777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xanthomonas maltophilia bacteremia in immunocompromised hematological patients.
    Victor MA; Arpi M; Bruun B; Jønsson V; Hansen MM
    Scand J Infect Dis; 1994; 26(2):163-70. PubMed ID: 8036472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
    Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
    APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study.
    Apisarnthanarak A; Mayfield JL; Garison T; McLendon PM; DiPersio JF; Fraser VJ; Polish LB
    Infect Control Hosp Epidemiol; 2003 Apr; 24(4):269-74. PubMed ID: 12725356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of epidemic and endemic isolates of Xanthomonas maltophilia by contour-clamped homogeneous electric field gel electrophoresis.
    VanCouwenbergh C; Cohen S
    Infect Control Hosp Epidemiol; 1994 Nov; 15(11):691-6. PubMed ID: 7852724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection.
    Pathmanathan A; Waterer GW
    Eur Respir J; 2005 May; 25(5):911-4. PubMed ID: 15863651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nosocomial and community-acquired Xanthomonas maltophilia infection in tropical Australia.
    Heath T; Currie B
    J Hosp Infect; 1995 Aug; 30(4):309-13. PubMed ID: 7499812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.
    Aisenberg G; Rolston KV; Dickey BF; Kontoyiannis DP; Raad II; Safdar A
    Eur J Clin Microbiol Infect Dis; 2007 Jan; 26(1):13-20. PubMed ID: 17200840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology and characteristics of 16 cases with Stenotrophomonas maltophilia bacteraemia in pediatric Intensive Care Units.
    Motamedifar M; Heidari H; Yasemi M; Sedigh Ebrahim-Saraie H
    Ann Ig; 2017; 29(4):264-272. PubMed ID: 28569336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Stenotrophomonas maltophilia Infections in Critically Ill Children.
    Tokatly Latzer I; Paret G; Rubinstein M; Keller N; Barkai G; Pessach IM
    Pediatr Infect Dis J; 2018 Oct; 37(10):981-986. PubMed ID: 29634621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital.
    Sattler CA; Mason EO; Kaplan SL
    Clin Infect Dis; 2000 Dec; 31(6):1321-30. PubMed ID: 11095997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transferable antibiotic resistance in nosocomial Stenotrophomonas maltophilia strain.
    Blahová J; Králiková K; Krcméry V; Torsová V
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):129-32. PubMed ID: 9401804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stenotrophomonas maltophilia ocular infections.
    Penland RL; Wilhelmus KR
    Arch Ophthalmol; 1996 Apr; 114(4):433-6. PubMed ID: 8602781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-cataract endophthalmitis caused by multidrug-resistant Stenotrophomonas maltophilia: clinical features and risk factors.
    Ji Y; Jiang C; Ji J; Luo Y; Jiang Y; Lu Y
    BMC Ophthalmol; 2015 Jan; 15():14. PubMed ID: 25618260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer.
    Khardori N; Elting L; Wong E; Schable B; Bodey GP
    Rev Infect Dis; 1990; 12(6):997-1003. PubMed ID: 2267495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.